Literature DB >> 24406413

Reply to Dr Grzybowski.

K G Falavarjani1, Q D Nguyen2.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24406413      PMCID: PMC3983627          DOI: 10.1038/eye.2013.302

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Is the use of topical antibiotics for intravitreal injections the standard of care or are we better off without antibiotics?

Authors:  Royce W S Chen; Aleksandra Rachitskaya; Ingrid U Scott; Harry W Flynn
Journal:  JAMA Ophthalmol       Date:  2013-07       Impact factor: 7.389

2.  Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection.

Authors:  Vivian T Yin; Daniel J Weisbrod; Kenneth T Eng; Carol Schwartz; Radha Kohly; Efrem Mandelcorn; Wai-Ching Lam; Nick Daneman; Andrew Simor; Peter J Kertes
Journal:  JAMA Ophthalmol       Date:  2013-04       Impact factor: 7.389

3.  The role of antibiotics in the prevention of post-intravitreal anti-VEGF endophthalmitis: primum non nocere!

Authors:  A Grzybowski
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

4.  [Prevention of post intravitreal injection endophthalmitis: is antibioprophylaxis indicated?].

Authors:  I Cochereau; J-F Korobelnik; B Bodaghi
Journal:  J Fr Ophtalmol       Date:  2012-12-13       Impact factor: 0.818

Review 5.  Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature.

Authors:  K Ghasemi Falavarjani; Q D Nguyen
Journal:  Eye (Lond)       Date:  2013-05-31       Impact factor: 3.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.